Filing Details

Accession Number:
0001179110-11-007785
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-11 17:37:01
Reporting Period:
2011-05-09
Filing Date:
2011-05-11
Accepted Time:
2011-05-11 16:37:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Ziopharm Oncology Inc ZIOP Services-Specialty Outpatient Facilities, Nec (8093) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1338535 Murray Brennan Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York NY 10021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.001 Par Value Disposition 2011-05-09 15,000 $6.57 52,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock, $.001 Par Value Director Stock Option $4.31 2006-12-22 2014-12-22 15,029 15,029 Direct
Common Stock Stock Option (right to buy) $5.01 2006-04-26 2016-04-26 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $6.49 2009-12-13 2016-12-13 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $4.85 2017-06-18 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $2.73 2017-12-12 20,000 20,000 Direct
Common Stock Stock Option (right to buy) $0.70 2019-05-13 15,000 15,000 Direct
Common Stock, $.001 Par Value Stock Option (right to buy) $2.85 2019-12-31 7,500 7,500 Direct
Common Stock, $.001 Par Value Stock Option (right to buy) $5.09 2011-03-31 2020-03-31 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $4.77 2020-12-31 30,000 30,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-12-22 15,029 15,029 Direct
2016-04-26 15,000 15,000 Direct
2016-12-13 15,000 15,000 Direct
2017-06-18 15,000 15,000 Direct
2017-12-12 20,000 20,000 Direct
2019-05-13 15,000 15,000 Direct
2019-12-31 7,500 7,500 Direct
2020-03-31 15,000 15,000 Direct
2020-12-31 30,000 30,000 Direct
Footnotes
  1. Proceeds from the sales reported on this form were used to offset the reporting person's payment of tax obligations triggered by the vesting of previously awarded restricted stock. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.55 to $6.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
  2. 5,000 shares vest on each of 6/18/08, 6/18/09 and 6/18/10.
  3. 6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
  4. 5,000 shares vest on each of 12/31/09, 6/30/10 and 12/31/10.
  5. 3,750 shares vest on each of 12/31/2010 and 12/31/2011.
  6. 10,000 shares vest on each of 12/31/2011, 12/31/2012 and 12/31/2013.
  7. Includes grants of restricted stock with restrictions that lapsed as to 3,750 shares on December 31, 2010 and as to 15,000 shares on March 31, 2011; and restrictions that will lapse as to 3,750 shares on December 31, 2011.